[go: up one dir, main page]

PL410186A1 - Method, application and a set for detecting high risk breast cancer with bad prognosis - Google Patents

Method, application and a set for detecting high risk breast cancer with bad prognosis

Info

Publication number
PL410186A1
PL410186A1 PL410186A PL41018614A PL410186A1 PL 410186 A1 PL410186 A1 PL 410186A1 PL 410186 A PL410186 A PL 410186A PL 41018614 A PL41018614 A PL 41018614A PL 410186 A1 PL410186 A1 PL 410186A1
Authority
PL
Poland
Prior art keywords
breast cancer
application
high risk
detecting high
bad prognosis
Prior art date
Application number
PL410186A
Other languages
Polish (pl)
Other versions
PL236572B1 (en
Inventor
Cezary Cybulski
Jan Lubiński
Original Assignee
Pomorski Uniwersytet Medyczny W Szczecinie
Cezary Cybulski
Jan Lubiński
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pomorski Uniwersytet Medyczny W Szczecinie, Cezary Cybulski, Jan Lubiński filed Critical Pomorski Uniwersytet Medyczny W Szczecinie
Priority to PL410186A priority Critical patent/PL236572B1/en
Publication of PL410186A1 publication Critical patent/PL410186A1/en
Publication of PL236572B1 publication Critical patent/PL236572B1/en

Links

Landscapes

  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)

Abstract

Wynalazek ujawnia sposoby i produkty znajdujące zastosowanie w diagnozowaniu genetycznej predyspozycji do chorób u ludzi i polega na ocenie czy w materiale biologicznym badanej osoby występuje specyficzna zmiana konstytucyjna w genie PALB2. Wynalazek dotyczy nowej metody diagnostycznej wykrywającej wysoką genetyczną predyspozycję do inwazyjnego raka piersi o złym rokowaniu. Sposób i zestaw diagnostyczny dotyczy opracowania nowego markera złego rokowania dla raka piersi.The invention discloses methods and products used in the diagnosis of genetic predisposition to human diseases and consists in assessing whether a specific constitutional change in the PALB2 gene occurs in the biological material of the examined person. The invention relates to a new diagnostic method detecting a high genetic predisposition to invasive breast cancer with poor prognosis. The method and diagnostic kit concerns the development of a new marker of poor prognosis for breast cancer.

PL410186A 2014-11-20 2014-11-20 Method, application and a set for detecting high risk breast cancer with bad prognosis PL236572B1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
PL410186A PL236572B1 (en) 2014-11-20 2014-11-20 Method, application and a set for detecting high risk breast cancer with bad prognosis

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PL410186A PL236572B1 (en) 2014-11-20 2014-11-20 Method, application and a set for detecting high risk breast cancer with bad prognosis

Publications (2)

Publication Number Publication Date
PL410186A1 true PL410186A1 (en) 2016-05-23
PL236572B1 PL236572B1 (en) 2021-01-25

Family

ID=55970673

Family Applications (1)

Application Number Title Priority Date Filing Date
PL410186A PL236572B1 (en) 2014-11-20 2014-11-20 Method, application and a set for detecting high risk breast cancer with bad prognosis

Country Status (1)

Country Link
PL (1) PL236572B1 (en)

Also Published As

Publication number Publication date
PL236572B1 (en) 2021-01-25

Similar Documents

Publication Publication Date Title
AR095363A1 (en) BIOMARKERS AND METHODS FOR THE TREATMENT OF CONDITIONS RELATED TO PD-1 AND PD-L1
BR112015023120A2 (en) method for identifying an individual with a disease or dysfunction, method for predicting the responsiveness of an individual with a disease or dysfunction, method for determining the likelihood that an individual with a disease or dysfunction will exhibit benefit from treatment, method for selecting a therapy, Uses of a pd-11 Axis Binding Antagonist, Assay to Identify an Individual with a Disease, Diagnostic Kit, Method to Evaluate a Treatment Response, and Method to Monitor the Response of a Treated Individual
WO2014020502A3 (en) Markers associated with sensitivity to inhibitors of human double minute 2 (mdm2)
WO2014140933A3 (en) Method for the prognosis and treatment of cancer metastasis
MX2015006757A (en) Method for evaluation of presence of or risk of colon tumors.
BR112014031365A2 (en) methods of detecting disease or conditions
GB2552267A (en) Detection and treatment of disease exhibiting disease cell heterogeneity and systems and methods for communicating test results
JP2014144959A5 (en)
BR112016007864A2 (en) Method for cancer prognosis and metastasis treatment
BR112014025269A2 (en) Method for cancer metastasis prognosis and treatment
EA201390150A1 (en) METHODS OF IDENTIFYING SIGNATURES OF DISEASE OR PATHOLOGICAL CONDITIONS IN THE FLOWS OF THE ORGANISM
BR112014031414A2 (en) methods of detecting disease or conditions using circulating diseased cells
MX2018009304A (en) Diagnostic and prognostic methods for cardiovascular diseases and events.
ATE554389T1 (en) APEX AS A MARKER FOR LUNG CANCER
MY195045A (en) Specific Biomarker Set For Non-Invasive Diagnosis of Liver Cancer
MX358474B (en) Specific salivary biomarkers for risk detection, early diagnosis, prognosis and monitoring of alzheimer's and parkinson's diseases.
WO2019074615A3 (en) In vitro methods for skin therapeutic compound discovery using skin age biomarkers
IN2014DN08398A (en)
BR112015019567A2 (en) markers associated with wnt inhibitors
MX363693B (en) Methods for determining prognosis of colorectal cancer.
IN2014DN08312A (en)
EA201490201A1 (en) DETECTION OF THE PRAME GENE EXPRESSION IN CANCER DISEASES
PL410186A1 (en) Method, application and a set for detecting high risk breast cancer with bad prognosis
WO2015181555A8 (en) Expression profiling for determining the responsiveness of cancers to treatment with an anti-angiogenic agent
WO2013188823A3 (en) Cancer prognostic assays